Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Cefdinir Capsules 300 mg
Teva Pharma GmbH
Healthy
2 trials -
Cefdinir for oral suspension 250 mg/5mL
Teva Pharma GmbH
Healthy
2 trials -
Cefprozil for oral suspension 250 mg/5 mL
Teva Pharma GmbH
Healthy
2 trials -
Cefzil® 500 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Celecoxib
Akebia Europe Limited
Healthy Volunteers
1 trial -
Cilostazol 100 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Cilostazol 50 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Ciprofloxacin XR + MMX Placebo
Takeda
Healthy
1 trial -
Clarithromycin
Teva Pharma GmbH
Healthy
2 trials -
Clarithromycin ER 500 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Clifutinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Adult Subject
1 trial -
Clindamycin 300 mg capsule
Teva Pharma GmbH
Healthy
2 trials -
Clinical Center Reference Endotoxin (CCRE)
United Therapeutics Europe Ltd
Healthy
1 trial -
Clopidogrel
Takeda
Healthy
1 trial -
Cohort 1 BEM + Ruzasvir
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Cohort 1: bococizumab 150 mg + rHuPH20
HALOZYME THERAPEUTICS, INC.
Healthy
1 trial -
D3560C00817
AstraZeneca AB
Clinical trial healthy volunteer
1 trial -
D3615C00005
AstraZeneca AB
Healthy participants
1 trial -
D5084C00016
AstraZeneca AB
Healthy Volunteers
1 trial -
D5985C00008
AstraZeneca AB
Not applicable, healthy volunteers
1 trial -
D5985C00009
AstraZeneca AB
Not applicable, healthy volunteers
1 trial -
D7260C00007
AstraZeneca AB
Not applicable, healthy volunteers
1 trial -
D9180C00011
AstraZeneca AB
healthy volunteers
1 trial -
D9440C00003
AstraZeneca AB
Healthy Volunteers, Renal Impairment and End Stage Kidney Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.